[ERBB2/HER2: from molecular to clinical oncology]

Vopr Onkol. 2002;48(2):137-45.
[Article in Russian]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents, Hormonal / pharmacology
  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / radiotherapy
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genes, erbB-2* / drug effects
  • Genes, erbB-2* / genetics
  • Humans
  • Prognosis
  • Protein-Tyrosine Kinases / genetics
  • Receptor, ErbB-2 / drug effects
  • Receptor, ErbB-2 / genetics*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Protein-Tyrosine Kinases
  • Receptor, ErbB-2
  • Trastuzumab